Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (1-10 of 243) with videos related to

Pageof 25
Sort By:
The Lancet. Oncology|November 28, 2018
Metastatic osteosarcoma challenged by regorafenibDominique Heymann
Current Pharmaceutical Design|August 21, 2010
Bisphosphonates and bone diseases: past, present and futureDominique Heymann
Current Opinion in Investigational Drugs (London, England : 2000)|May 30, 2006
Autophagy: A protective mechanism in response to stress and inflammationDominique Heymann
Journal of Bone Oncology|February 25, 2016
Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesDominique Heymann
Frontiers in Public Health|January 25, 2021
The Elderly and the COVID 19 Crisis: A Chronicle of Deaths Foretold, in Isolation and Total IndifferenceDominique Heymann
Frontiers in Oncology|January 19, 2016
Bone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaFrançoise Redini, Dominique Heymann
Bonekey Reports|January 15, 2014
Targeted therapies for bone sarcomasDominique Heymann, Françoise Rédini
Expert Review of Clinical Pharmacology|January 6, 2012
Pharmacodynamics of bisphosphonates in arthritisBenoit Le Goff, Dominique Heymann
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Exosomal lncRNAs: the newest promising liquid biopsyMarta Tellez-Gabriel, Dominique Heymann
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Modulatory effects of proteoglycans on proteinase activitiesSteven Georges, Dominique Heymann, Marc Padrines
Pageof 25

Showing results (1-10 of 243) with videos related to

Sort By:
Pageof 25
The Lancet. Oncology|November 28, 2018
Metastatic osteosarcoma challenged by regorafenibDominique Heymann
Current Pharmaceutical Design|August 21, 2010
Bisphosphonates and bone diseases: past, present and futureDominique Heymann
Current Opinion in Investigational Drugs (London, England : 2000)|May 30, 2006
Autophagy: A protective mechanism in response to stress and inflammationDominique Heymann
Journal of Bone Oncology|February 25, 2016
Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesDominique Heymann
Frontiers in Public Health|January 25, 2021
The Elderly and the COVID 19 Crisis: A Chronicle of Deaths Foretold, in Isolation and Total IndifferenceDominique Heymann
Frontiers in Oncology|January 19, 2016
Bone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaFrançoise Redini, Dominique Heymann
Bonekey Reports|January 15, 2014
Targeted therapies for bone sarcomasDominique Heymann, Françoise Rédini
Expert Review of Clinical Pharmacology|January 6, 2012
Pharmacodynamics of bisphosphonates in arthritisBenoit Le Goff, Dominique Heymann
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Exosomal lncRNAs: the newest promising liquid biopsyMarta Tellez-Gabriel, Dominique Heymann
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Modulatory effects of proteoglycans on proteinase activitiesSteven Georges, Dominique Heymann, Marc Padrines
Pageof 25